91423-84-6

Basic information

• Product Name: Hexanoic acid, 2-bromo-, (2S)-
• Synonyms: Hexanoic acid, 2-bromo-, (2S)-
• CAS NO: 91423-84-6
• Molecular Formula: C₆H₁₁BrO₂
• Molecular Weight: 195
• Mol File: 91423-84-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 101-103 °C(Press: 2 Torr)
• Appearance: /
• Density: 1.436±0.06 g/cm3(Predicted)
• PKA: 2.97±0.21(Predicted)
• CAS DataBase Reference: Hexanoic acid, 2-bromo-, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Hexanoic acid, 2-bromo-, (2S)-(91423-84-6)
• EPA Substance Registry System: Hexanoic acid, 2-bromo-, (2S)-(91423-84-6)

Safety Data

• Hazardous Substances Data: 91423-84-6(Hazardous Substances Data)

Upstream product

• 615-96-3 Ethyl 2-bromohexanoate 
• 167823-35-0 1,2:5,6-di-O-isopropylidene-α-D-glucofuranos-3-O-yl α-bromohexanoate 
• 13894-63-8 methyl (E)-hex-2-enoate 
• 931382-07-9 C₇H₁₁BrO₂ 
• 616-05-7 2-bromohexanoic acid 
• 71-36-3 butan-1-ol 
• 142-62-1 hexanoic acid 
• 59045-37-3 1,2;5,6-di-O-(1-methylethylidene)-α-D-glucofuranosyl hexanoate 
• 327-56-0 D-norleucine 

Downstream Products

• 327-56-0 D-norleucine 
• 616-05-7 (R)-(+)-2-bromohexanoic acid 
• 43201-07-6 (R)-2-hydroxyhexanoic acid 
• 200949-68-4 Boc-D-Phe-Gln-Trp-Ala-Val-Gly-His-LeuΨ(CH2O)Nle-NH2 
• 200949-67-3 4-{(S)-2-Benzyloxycarbonylamino-2-[(S)-1-((S)-1-carbamoyl-pentyloxymethyl)-3-methyl-butylcarbamoyl]-ethyl}-imidazole-1-carboxylic acid benzyl ester 
• 636-36-2 rac-2-hydroxyhexanoic acid 
• 130336-10-6 (2R,4S)-3-oxa-2-butyl-4-<<4-(1,3-dioxabutyl)piperidin-1-yl>carbonyl>-5-phenylpentanoic acid 
• 130336-10-6 (2S,4S)-3-oxa-2-butyl-4-<<4-(1,3-dioxabutyl)piperidin-1-yl>carbonyl>-5-phenylpentanoic acid 
• 141047-78-1 (S)-2-((S)-1-Benzyl-2-oxo-2-piperidin-1-yl-ethoxy)-hexanoic acid 
• 5445-19-2 methyl ester of/the/ L(-)-2-bromo-caproic acid 

Relevant articles and documents

Enoate reductase-mediated preparation of methyl (S)-2-bromobutanoate, a useful key intermediate for the synthesis of chiral active pharmaceutical ingredients

Enoate reductases belonging to the Old Yellow Enzyme (OYE) family were employed to develop a biocatalysed approach to methyl (S)-2-bromobutanoate, a key intermediate for the introduction of a particular stereogenic unit into the molecular skeleton of a certain class of chiral drugs. Methyl (Z)-2-bromocrotonate afforded, respectively, (S)-2-bromobutanoic acid (ee = 97%) and methyl (S)-2-bromobutanoate (ee = 97%) by baker's yeast fermentation and by OYE1-3 biotransformations. The bioreductions of other methyl 2-haloalkenoates were also considered. It was observed that the (Z)- and (E)-diastereoisomers of α-bromo unsaturated esters afforded the same enantiomer of the corresponding reduced product.

Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1

Through directed screening of compounds prepared as metalloprotease inhibitors a compound, CGS 30084, that had potent endothelin converting enzyme-1 (ECE-1) in vitro inhibitory activity (IC50=77nM) was identified. Herein we report the synthesis and optimization of ECE-1 inhibitory activity of additional analogues from this lead. Compound 3c, the thioacetate methyl ester derivative of compound 4c, was found to be a long acting inhibitor of ECE-1 activity in rats after oral administration. (C) 2000 Elsevier Science Ltd.

Asymmetric Synthesis of 2-Chloro- and 2-Bromo-alkanoic acids by Halogenation of α-D-Glucofuranose-Derived Silyl Ketene Acetals.

Optically active (S)-2-bromo- and 2-chloro-alkanoic acids 6 and 7 have been obtained via the diastereoselective halogenation of chiral silyl ketene acetals 3a-f, and subsequent saponification of the resulting crude esters.Examples characterized by e.e. values up to 95percent are reported.The diastereoface selectivity is independent of the silyl ketene acetal E/Z configuration.